A second major Wall Street bank this week is telling clients to cash in tech stocks. Here's why

RBC downgraded the tech sector from overweight to market weight, citing decelerating upward EPS estimate revisions in semiconductors; Deutsche Bank had also warned that the tech rotation’s risk-reward was no longer favorable in the near term. The iShares Semiconductor ETF fell almost 3% Wednesday, more than 5% this week and over 19% below its late-June 52-week high; VanEck’s semiconductor ETF was down more than 2% Wednesday and 5.5% in October. Investors and strategists also raised concerns about AI capital spending returns, although the timing of any downturn remains uncertain.

Analysis

The signal is a change in the rate of estimate upgrades, not evidence that semiconductor earnings are already contracting. That distinction matters: if revisions merely slow while estimates remain positive, the sector can de-rate without an immediate earnings collapse. Recent strength in Micron (MU) and Sandisk (SNDK) may leave their shares especially exposed to a sentiment reversal; however, memory demand and pricing are not interchangeable with the broader semiconductor complex, so avoid treating either as a clean proxy for all AI capex.

Over the next 1–3 months, monitor semiconductor estimate-revision breadth, memory pricing, and hyperscaler spending commentary. A sustained slowdown in upgrades could prompt multiple compression and broaden outflows from SOXX/SMH; a pause in revisions followed by renewed upgrades would undercut the bearish rotation thesis. Over 6–18 months, the bigger risk is that AI capacity becomes abundant before customers generate returns sufficient to justify investment—potentially pressuring equipment orders and supplier economics. The timing is highly uncertain, and bearish commentary alone is not confirmation of capital destruction.

Contrarian point: after a material pullback in semiconductor ETFs, consensus warnings may already be partly reflected in prices. A tactical underweight is better framed as a hedge than an aggressive outright short until revisions or company guidance confirm deterioration.

Key Decisions for Investors

• Consider a modest 1–3 month relative-value position: underweight SOXX against the Health Care Select Sector SPDR (XLV), rather than making a high-conviction outright semiconductor short. Scale in only if semiconductor estimate-upgrade breadth continues to weaken.
• For existing MU or SNDK exposure, trim risk or use defined-risk protection rather than extrapolating recent gains. Reassess after company results and updates on memory pricing, order trends, and customer demand; the article does not establish company-specific earnings deterioration.
• Falsify the cautious view if semiconductor upgrade breadth stabilizes or improves and MU/SNDK guidance and relevant pricing indicators remain firm. A renewed downgrade cycle, weaker guidance, or evidence of delayed AI-related orders would strengthen it.
• Treat the 2027 AI-capex concern as a longer-dated risk, not a near-term timing signal. Track hyperscaler return-on-investment commentary and spending plans; absent deterioration there, avoid paying heavily for long-dated downside.